Relapses increase post Tysabri
Another study finds that stopping natalizumab (Tysabri) or switching to another disease modifying drug led to an increased risk of relapses.
2 Minute Medicine
Natalizumab (Tysabri) - A to Z of MS
Source: Multiple Sclerosis Trust - Category: Neurology Source Type: news